Real-World Implications of the American Gastroenterology Association Nonalcoholic Fatty Liver Disease Clinical Care Pathway in the US Adult Population

Abstract

One of the challenges in caring for patients with nonalcoholic fatty liver disease (NAFLD) is to identify those at the highest risk for clinically significant liver disease. 1 Kanwal F. et al. Metabolism. 2021; 122: 154822 Abstract Full Text Full Text PDF PubMed Scopus (13) Google Scholar In 2021, the American Gastroenterology Association (AGA) published the 2021 NAFLD Care Pathway that provides a stepwise algorithm to identify adults at risk for NAFLD who have elevated risk for clinically significant hepatic fibrosis and should be referred to hepatology. 2 Kanwal F. et al. Gastroenterology. 2021; 161: 1657-1669 Abstract Full Text Full Text PDF PubMed Google Scholar